Vitals, Georgia Life Sciences' podcast series, developed in partnership with Cloudcast Media, highlights the dynamic and rapidly growing life sciences ecosystem in Georgia. It provides insights into the people, organizations, and innovations that are shaping the future of life sciences in the state. This podcast serves as a valuable resource for entrepreneurs, investors, policymakers, and anyone interested in learning more about Georgia's role in the life sciences industry.
Sponsorship opportunities available. Please contact Stacey Bowlin to learn more.
Listen on your favorite podcast platform and subscribe to stay updated on new episodes!
🎙️ S2, E5 - A Neutral Party in Cancer Care: Collaboration, Clinical Trials, and Quality of Life
In this incredible, timely, and informative episode of VITALS, Maria Thacker, the CEO of Georgia Life Sciences, interviews Lynn Durham, President and CEO of Georgia Core, who discusses her journey from government and politics to leading a nonprofit focused on cancer care. Georgia Core, founded in 2003, aims to improve cancer care through research, education, and advocacy.
🎙️ S2, E4 - Homegrown Innovation: Microneedle Stamps for the Food Allergy Epidemic
In this incredible, timely, and informative episode of VITALS, Maria Thacker, the CEO of Georgia Life Sciences, interviews Dr. Samir Patel, President and CEO of Moonlight Therapeutics, who discusses the company's development of a micro-needle stamp for food allergy treatment.
🎙️ S2, E3 - Using AI to Augment and Accelerate Life Sciences Innovation
In this episode of the Vitals podcast, hear from Mike Walker, Global Healthcare and Life Sciences Digital Strategy, Microsoft.
🎙️ S2, E2 - Knowledge is Power in Optimizing the Funding Stack and Valuation
In this episode of the Vitals podcast, hear from David Crean, Venture Partner at 1004 Venture Partners.
🎙️ S2, E1 - The Biology Century: The Convergence of Public Health, Economic Growth, and National Security
John Crowley, President and CEO of BIO, shared his journey from business to biotech after his daughter Megan was diagnosed with Pompe Disease. He emphasized the importance of time in biotech, highlighting the transformation of cystic fibrosis treatment from a death sentence to a normal life expectancy.
